MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2019 International Congress

    Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience

    V. Veerappan, M. Brodsky (Portland, OR, USA)

    Objective: To describe characteristics of patients with secondary limb dystonia in Parkinson’s Disease, types of dystonia observed, and treatment/response with chemodenervation. Background: Dystonia can be…
  • 2019 International Congress

    Hemifacial Spasm and Related Comorbidities

    A. Akyol Gurses, N. Kiylioglu, A. Akyol (Aydin, Turkey)

    Objective: In this study, we evaluated the clinical findings, comorbidities and teratment responses in our HFS patients. Background: Hemifacial spasm (HFS) is a peripherally induced…
  • 2019 International Congress

    Central effects of botulinum neurotoxin injections in cervical dystonia – a longitudinal structural MRI-study

    D. Weise, C. Awissus, P. Baum, J. Classen, A. Villringer, P. Ragert, C. Weise (Leipzig, Germany)

    Objective: To investigate if cervical dystonia (CD) patients show structural grey matter changes and if these changes may be associated with previous botulinum neurotoxin (BoNT)…
  • 2019 International Congress

    Impact of fixed or flexible abobotulinumtoxinA injection intervals on patient outcomes: Analyses from a 3-year observational study following patients with cervical dystonia

    C. Colosimo, T. Chung, D. Charles, V. Misra, S. Om, P. Maisonobe (Terni, Italy)

    Objective: This post-hoc analysis assessed the impact of fixed or flexible injection schedules on outcomes in patients receiving abobotulinumtoxinA (aboBoNT-A) for cervical dystonia (CD) in…
  • 2019 International Congress

    Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity

    L. Rocchi, A. Latorre, G. Paparella, E. Menozzi, L. Peppoloni, F. Valero-Cuevas, C. Cordivari, K. Bhatia, J. Rothwell (London, United Kingdom)

    Objective: To assess improvement in hand function following therapy with botulinum toxin in patients with dystonic tremor (DT). Background: Treatment of dystonic tremor (DT) with…
  • 2018 International Congress

    Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

    R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)

    Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…
  • 2018 International Congress

    A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

    W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)

    Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…
  • 2018 International Congress

    Response to botulinum toxin in adult onset lower limb dystonia

    D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)

    Objective: To describe the response to treatment with botulinum toxin in a cohort with adult onset lower limb dystonia. Background: Adult onset, lower limb dystonia…
  • 2018 International Congress

    Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia

    C. Comella, A. Brashear, J. Jankovic, D. Truong, A. Patel, M. Evatt, N. Kapa, Y. Liu, T. Nguyen-Cleary (Chicago, IL, USA)

    Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…
  • 2018 International Congress

    Botulinum toxin A injection for treatment of adductor spasmodic dysphonia under guidance of fiber laryngoscope combined with needle electromyography: 2 case reports

    X. Zhang, Z. Zhang, Y. Pan, L. Jin (Shanghai, China)

    Objective: To report two cases of adductor spasmodic dysphonia that treated with botulinum toxin A under fiber laryngoscope combined with needle electromyography guidance. Background: Spasmodic…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley